newsfilter
← Latest News
GlobeNewswire·

Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer

SAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (("Olema" or "Olema Oncology", NASDAQ:OLMA), a clinical-stage biopharmaceutical company focused on the discovery,